Lyon, le 5 février 2020 - MaaT Pharma annonce aujourd'hui une levée de fonds de…
nboutaouiFebruary 4, 2020
Lyon, France, November 6, 2019 – MaaT Pharma announced today that a poster will…
nboutaouiNovember 6, 2019
Jean-Marc Renard, MS, MBA, joins as Chief Business Officer Emmanuel Prestat, PhD, joins as Computational…
nboutaouiSeptember 10, 2019
Independent Data Safety Monitoring Board (DSMB) confirms continuation of Phase II HERACLES study in acute…
nboutaouiJune 24, 2019
- First patents to cover the fundamental processes for accessing the human gut microbiome as…
nboutaouiMay 21, 2019
“Caelus Health, EnteroBiotix, Ferring Pharmaceuticals, and MaaT Pharma, in coordination with the Pharmabiotic Research Institute…
nboutaouiMay 21, 2019
MaaT Pharma Announces Second Positive DSMB Safety Assessment of Phase II HERACLES Study in Acute…
nboutaouiApril 9, 2019
Independent Data Safety Monitoring Board (DSMB) recommends to continue HERACLES study without modification. Lyon, France,…
nboutaouiFebruary 5, 2019
Data show achievement of primary endpoint, demonstration of functional microbiota restoration, inflammation reduction and positive…
nboutaouiDecember 2, 2018